New blood test may help Fine-Tune diabetes treatment faster
NCT ID NCT05227677
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether using a blood marker called glycated albumin (GA) to guide diabetes treatment works better than the usual HbA1c test. 200 adults newly diagnosed with type 2 diabetes were split into two groups: one where doctors used GA levels to adjust medication, and another where they followed standard guidelines. The goal was to see if the GA-guided group achieved better blood sugar control after 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Haidian Hospital
Beijing, China
-
Beijing Pinggu District Hospital
Beijing, China
-
Beijing Shijingshan Hospital
Beijing, China
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, China
-
Civil Aviation General Hospital
Beijing, China
-
Peking University People's Hospital
Beijing, China
-
The third people's hospital of DATONG
Datong, Shanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Could a peptide injection help rebuild Insulin-Making cells?
- A pill for diabetes? new oral drug aims to rival injections